Navigation Links
Regeneron Announces March 2011 Investor Conference Presentations
Date:2/23/2011

TARRYTOWN, N.Y., Feb. 23, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations at the following investor conferences:

  • Citi 2011 Global Healthcare Conference at 9:00 a.m. Eastern Time on Tuesday, March 1, 2011

  • RBC Capital Markets' 2011 Healthcare Conference at 10:00 a.m. Eastern Time on Wednesday, March 2, 2011

  • Cowen and Company 31st Annual Healthcare Conference at 1:20 p.m. Eastern Time on Tuesday, March 8, 2011

  • Barclays Capital 2011 Global Healthcare Conference at 9:00 a.m. Eastern Time on Wednesday, March 16, 2011

  • The sessions may be accessed through the Company’s web site, www.regeneron.com, on the Investor Relations page.  Archived versions of the presentations will be available for thirty days after the live webcasts.

    Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.  In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-related macular degeneration and central retinal vein occlusion), and certain cancers.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions and cancer.  Additional information about Regeneron and recent news releases are available on Regeneron's web site at www.regeneron.com.Contact Information:Michael Aberman, M.D.

    Peter DworkinInvestor Relations

    Corporate Communications914.345.7799

    914.345.7800michael.aberman@regeneron.com

    peter.dworkin@regeneron.com
    '/>"/>

    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
    2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
    3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
    4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
    5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
    6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
    7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
    8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
    9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
    10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
    11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2016)... 2016 Gamida Cell, a leader ... cancer and orphan genetic diseases, announced today it has ... from the Israel Innovation Authority (formerly the Office of ... and Industry. The mission of the Israel Innovation Authority ... including science and technology, while stimulating economic growth. ...
    (Date:5/20/2016)... , May 20, 2016 ... veteran investors believe that the industry is not far ... and today ActiveWallSt.com featured the following four equities: Anacor ... (NASDAQ: ATHX ), Aralez Pharmaceuticals Inc. (NASDAQ: ... INFI ). Sign up for your free ...
    (Date:5/19/2016)... PARIS , May 19,2016 ... Activities at Digestive Disease Week Meeting and 91 ... Society Mauna Kea Technologies (Euronext: MKEA, ... laser endomicroscopy platform, today announced that its Cellvizio ... meeting focused on gastroenterology during the month of ...
    Breaking Medicine Technology:
    (Date:5/24/2016)... ... May 24, 2016 , ... PhysicianOne Urgent Care, advocators in helping their ... and how to avoid being bitten this spring. , The official tick season ... small spider-like insects, are known for attaching themselves to their prey while they feed ...
    (Date:5/24/2016)... ... 24, 2016 , ... Design Concepts , a national ... Quinto Sol Wheel Park’ in Pueblo, Colorado. This park was designed working with ... for this often overlooked neighborhood. Located at 609 E. 6th Street, Pueblo’s newest ...
    (Date:5/24/2016)... ... May 24, 2016 , ... ... imaging; multiplex immunoassays are widely used for cell and protein analysis. Keeping updated ... their quality and efficiency in these areas. , LabRoots introduces a new ...
    (Date:5/24/2016)... ... May 24, 2016 , ... NutraPre today ... beverage for pregnant women to prevent morning sickness and promote overall heath. Engineered ... the look and taste of water. , “Imagine a pregnancy without morning sickness,” ...
    (Date:5/23/2016)... NY (PRWEB) , ... May 23, 2016 , ... On ... Ferdico took the time to summarize the weight loss process: , New patients have ... Body Composition Analysis (BCA) to get accurately evaluated. , Body Composition Analysis, There are ...
    Breaking Medicine News(10 mins):